MiDeTe - microRNA Levels Under Denosumab and Teriparatide Therapy in Postmenopausal Osteoporosis
Status:
Active, not recruiting
Trial end date:
2022-09-30
Target enrollment:
Participant gender:
Summary
The aim of this study is the quantitative determination of bone-specific microRNAs in the
serum of postmenopausal women with osteoporosis during antiresorptive or osteoanabolic
therapy.